Issi Rozen, M.B.A.
Issi Rozen is the senior advisor to the director at the Broad Institute of Harvard and MIT. He previously served as the institute's chief business officer and his responsibilities included developing innovative scientific and business collaborations with life sciences companies, technology companies, and venture investors. He was also responsible for initiating and establishing new ventures around novel technologies and for overseeing strategy and licensing of the institute’s intellectual property portfolio. Rozen is also a venture partner at GV, where he focuses on the formation of new companies and early-stage investments.
Rozen joined the Broad in 2011 after a career in the biotech industry, where he led strategy and business development efforts at a number of venture-backed start-ups. Before that, he headed the business analysis group at a large biotech where he was responsible for evaluating in-licensing and M&A opportunities, as well as commercial analytics and forecasting for pipeline and commercial products. Rozen is a founder and strategic advisor of Verve Therapeutics, a member of the scientific advisory board of Cyclica, and a member of the board of directors of iZotope and Sherlock Biosciences.
Rozen is also an accomplished jazz guitarist and former professor at Berklee College of Music. He earned his M.B.A. at MIT’s Sloan School of Management.